266 related articles for article (PubMed ID: 15610719)
1. Phenotype of hepatic infiltrates and hepatic lymph nodes of lambs primarily and challenge infected with Fasciola hepatica, with and without triclabendazole treatment.
Pérez J; Ortega J; Bravo A; Díez-Baños P; Morrondo P; Moreno T; Martínez-Moreno A
Vet Res; 2005; 36(1):1-12. PubMed ID: 15610719
[TBL] [Abstract][Full Text] [Related]
2. Pathological and immunohistochemical study of the liver and hepatic lymph nodes of sheep chronically reinfected with Fasciola hepatica, with or without triclabendazole treatment.
Pérez J; Ortega J; Moreno T; Morrondo P; López-Sández C; Martínez-Moreno A
J Comp Pathol; 2002 Jul; 127(1):30-6. PubMed ID: 12354543
[TBL] [Abstract][Full Text] [Related]
3. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hepatic damage and local immune response in goats immunized with native glutathione S-transferase of Fasciola hepatica.
Zafra R; Pérez-Ecija RA; Buffoni L; Mendes RE; Martínez-Moreno A; Martínez-Moreno FJ; Galisteo ME; Pérez J
J Comp Pathol; 2010; 143(2-3):110-9. PubMed ID: 20185148
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
[TBL] [Abstract][Full Text] [Related]
7. Study of the local immune response to Fasciola hepatica in the liver and hepatic lymph nodes of goats immunised with a peptide of the Sm14 antigen.
Zafra R; Buffoni L; Pérez-Ecija RA; Mendes RE; Martínez-Moreno A; Martínez-Moreno FJ; Pérez J
Res Vet Sci; 2009 Oct; 87(2):226-32. PubMed ID: 19345386
[TBL] [Abstract][Full Text] [Related]
8. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves.
Craig TM; Huey RL
Am J Vet Res; 1984 Aug; 45(8):1644-5. PubMed ID: 6476577
[TBL] [Abstract][Full Text] [Related]
10. A 2.9 kDa Fasciola hepatica-recombinant protein based ELISA test for the detection of current-ovine fasciolosis trickle infected.
Arias M; Hillyer GV; Sánchez-Andrade R; Suárez JL; Pedreira J; Lomba C; Díaz P; Morrondo P; Díez-Baños P; Paz-Silva A
Vet Parasitol; 2006 Apr; 137(1-2):67-73. PubMed ID: 16417971
[TBL] [Abstract][Full Text] [Related]
11. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
[TBL] [Abstract][Full Text] [Related]
12. [Fasciolinip-1: experimental fasciolicidal activity in sheep].
Ibarra-Velarde F; Vera-Montenegro Y; Olazarán-Jenkins S; Hernández-Campos A; Castillo-Bocanegra R
Rev Latinoam Microbiol; 1995; 37(2):171-8. PubMed ID: 8552877
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Foxp3
Escamilla A; Zafra R; Pérez J; McNeilly TN; Pacheco IL; Buffoni L; Martínez-Moreno FJ; Molina-Hernández V; Martínez-Moreno A
Vet Parasitol; 2016 Oct; 230():14-19. PubMed ID: 27884436
[TBL] [Abstract][Full Text] [Related]
14. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep.
Maes L; Vanparijs O; Lauwers H; Deckers W
Vet Rec; 1990 Nov; 127(18):450-2. PubMed ID: 2275080
[TBL] [Abstract][Full Text] [Related]
16. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica.
Mendes RE; Pérez-Ecija RA; Zafra R; Buffoni L; Martínez-Moreno A; Dalton JP; Mulcahy G; Pérez J
Vaccine; 2010 Apr; 28(16):2832-40. PubMed ID: 20153792
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of the local immune response to Fasciola hepatica in primarily and secondarily infected goats.
Pérez J; de las Mulas JM; De Lara FC; Gutierrez-Palomino PN; Becerra-Martel C; Martínez-Moreno A
Vet Immunol Immunopathol; 1998 Aug; 64(4):337-48. PubMed ID: 9764726
[TBL] [Abstract][Full Text] [Related]
20. Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
Vet Parasitol; 2011 Apr; 177(1-2):79-89. PubMed ID: 21163580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
